Evolva Holding SA EVOLVA HOLDING ORD SHS
Evolva Holding SA EVOLVA HOLDING .../ CH1262055788 /
0QQJ
|
23/05/2024 14:30:14
|
Chg.
-
|
Volume |
Bid06:00:06 |
Demandez à06:00:06 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
0.9020CHF
|
-
|
60
Chiffrre d'affaires: 54.1200 |
-Bid taille: - |
-Ask la taille: - |
4.95 Mio.CHF |
- |
- |
Description de l'entreprise
Evolva Holding SA (formerly Arpida AG) is a Swiss synthetic biology company, internationally active in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva uses biosynthetic and evolutionary technologies to artificially create and optimise small molecule compounds and their production routes. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. Evolva is active in consumer healthcare and nutrition as well as in pharma. In both areas they have partnered projects as well as own proprietary programmes.
Conseil d'administration & Conseil de surveillance
| PDG |
| Christian Wichert |
| Conseil d'administration |
| Carsten Däweritz, Anne De Vos, Astrid Schäfer, Gerhard Lobmaier, Philipp Frech |
| Conseil de surveillance |
| Stephan Schindler, Beat In-Albon, Christoph Breucker, Andreas Pfluger, Andreas Weigelt |
Données de l'entreprise
| Nom: |
Evolva Holding SA |
| Adresse: |
Duggingerstraße 23,CH-4153 Reinach |
| Téléphone: |
+41-61-485-2000 |
| Fax: |
+41-61-485-2001 |
| Courriel: |
info@evolva.com
|
| Internet: |
www.evolva.com |
| Industrie: |
Biotechnology |
| Secteur: |
Biotechnology |
| Sous-secteur: |
Biotechnology |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
69.53% |
| IPO date: |
26/04/2023 |
Relations avec les investisseurs
| Nom: |
Doris Rudischhauser |
| Téléphone IR: |
+41-79-410-81-88 |
| IR-Fax: |
- |
| E-mail IR: |
dorisr@evolva.com
|
